INNOVA CAPTAB Financial Statement Analysis
|
||
|
The Revenues of INNOVA CAPTAB have increased by 15.72% YoY .
The Earnings Per Share (EPS) of INNOVA CAPTAB has decreased by -97.34 % YoY. |
||
| REVENUES |
| OPERATING MARGIN |
| PROFIT AFTER TAX |
| EPS |
| ROCE |
INNOVA CAPTAB Last 5 Annual Financial Results
[BOM: 544067|NSE : INNOVACAP]
| Consolidated | Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 |
|---|---|---|---|---|---|
| Revenues | ₹926 Cr | ₹801 Cr | ₹411 Cr | ₹373 Cr | ₹356 Cr |
| Expenses | ₹813 Cr | ₹705 Cr | ₹356 Cr | ₹322 Cr | ₹315 Cr |
| Operating Profit (Excl OI) | ₹114 Cr | ₹96 Cr | ₹54 Cr | ₹51 Cr | ₹41 Cr |
| Other Income | ₹9.20 Cr | ₹2.88 Cr | ₹1.37 Cr | ₹1.30 Cr | ₹0.22 Cr |
| Interest | ₹20 Cr | ₹5.68 Cr | ₹3.93 Cr | ₹4.63 Cr | ₹5.58 Cr |
| Depreciation | ₹11 Cr | ₹7.50 Cr | ₹5.59 Cr | ₹10 Cr | ₹11 Cr |
| Profit Before Tax | ₹92 Cr | ₹86 Cr | ₹46 Cr | ₹38 Cr | ₹25 Cr |
| Profit After Tax | ₹68 Cr | ₹64 Cr | ₹35 Cr | ₹28 Cr | ₹20 Cr |
| Consolidated Net Profit | ₹68 Cr | ₹64 Cr | ₹34 Cr | ₹28 Cr | ₹20 Cr |
| Earnings Per Share (Rs) | ₹14.15 | ₹531.54 | ₹286.86 | ₹232.23 | ₹166.01 |
| PAT Margin (%) | 7.21 | 7.91 | 8.38 | 7.46 | 5.58 |
| ROE(%) | 28.02 | 36.19 | 27.04 | 28.92 | 24.10 |
| ROCE(%) | 24.34 | 30.64 | 28.42 | 26.48 | 19.63 |
| Total Debt/Equity(x) | 0.85 | 0.95 | 0.31 | 0.48 | 0.87 |
Key Financials |
||
| Market Cap | : | ₹ 2,876.9 Cr |
| Revenue (TTM) | : | ₹ 1,069.6 Cr |
| Net Profit(TTM) | : | ₹ 86.4 Cr |
| EPS (TTM) | : | ₹ 15.1 |
| P/E (TTM) | : | 33.3 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| INNOVA CAPTAB | 5.1% | 7% | NA |
| SUN PHARMACEUTICAL INDUSTRIES | 0.9% | 1.2% | 63.5% |
| CIPLA | 2.7% | 7.3% | 52% |
| DR REDDYS LABORATORIES | -1.6% | -2.7% | 29.9% |
| ZYDUS LIFESCIENCES | 9.1% | 18% | 112.8% |
| DIVIS LABORATORIES | 3.2% | 9.5% | 20.2% |
| MANKIND PHARMA | -4.8% | -10.7% | 55.8% |
| TORRENT PHARMACEUTICALS | 1.2% | 5.7% | 63.4% |
| LUPIN | 2.7% | 8.8% | 112.5% |
INNOVA CAPTAB Revenues
[BOM: 544067|NSE : INNOVACAP]
| Y-o-Y | 15.72 % |
| 5 Yr CAGR | 27.03 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2023 | ₹926 Cr | 15.72 | |
| Mar2022 | ₹801 Cr | 94.94 | |
| Mar2021 | ₹411 Cr | 10.00 | |
| Mar2020 | ₹373 Cr | 4.92 | |
| Mar2019 | ₹356 Cr | - | |
INNOVA CAPTAB Operating Profit
[BOM: 544067|NSE : INNOVACAP]
| Y-o-Y | 18.36 % |
| 5 Yr CAGR | 29.20 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2023 | ₹114 Cr | 18.36 | |
| Mar2022 | ₹96 Cr | 76.23 | |
| Mar2021 | ₹54 Cr | 6.98 | |
| Mar2020 | ₹51 Cr | 24.88 | |
| Mar2019 | ₹41 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | 2.34 % |
| 5 Yr CAGR | 1.72 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2023 | 12.27% | 2.34 | |
| Mar2022 | 11.99% | -9.65 | |
| Mar2021 | 13.27% | -2.71 | |
| Mar2020 | 13.64% | 19.02 | |
| Mar2019 | 11.46% | - | |
INNOVA CAPTAB Profit After Tax
[BOM: 544067|NSE : INNOVACAP]
| Y-o-Y | 6.45 % |
| 5 Yr CAGR | 35.88 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2023 | ₹68 Cr | 6.45 | |
| Mar2022 | ₹64 Cr | 85.30 | |
| Mar2021 | ₹34 Cr | 23.53 | |
| Mar2020 | ₹28 Cr | 39.89 | |
| Mar2019 | ₹20 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | -8.85 % |
| 5 Yr CAGR | 6.62 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2023 | 7.21 % | -8.85 | |
| Mar2022 | 7.91 % | -5.61 | |
| Mar2021 | 8.38 % | 12.33 | |
| Mar2020 | 7.46 % | 33.69 | |
| Mar2019 | 5.58 % | - | |
INNOVA CAPTAB Earnings Per Share (EPS)
[BOM: 544067|NSE : INNOVACAP]
| Y-o-Y | -97.34 % |
| 5 Yr CAGR | -45.97 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2023 | ₹14 | -97.34 | |
| Mar2022 | ₹532 | 85.30 | |
| Mar2021 | ₹287 | 23.52 | |
| Mar2020 | ₹232 | 39.89 | |
| Mar2019 | ₹166 | - | |
INNOVA CAPTAB Return on Capital Employed (ROCE)
[BOM: 544067|NSE : INNOVACAP]
| Y-o-Y | -20.56 % |
| 5 Yr CAGR | 5.52 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2023 | 24.34% | -20.56 | |
| Mar2022 | 30.64% | 7.81 | |
| Mar2021 | 28.42% | 7.33 | |
| Mar2020 | 26.48% | 34.90 | |
| Mar2019 | 19.63% | - | |
INNOVA CAPTAB Share Price vs Sensex
| Current Share Price | : | ₹503.0 |
| Current MarketCap | : | ₹ 2,876.9 Cr |
| Updated EOD on | : | May 21,2024 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INNOVA CAPTAB | 5.1% |
7% |
|
| SENSEX | 1.2% |
2% |
19.4% |
INNOVA CAPTAB related INDICES
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| S&P BSE SMALL CAP | 3.8% | 5.3% | 60.7% |
| S&P BSE MIDSMALLCAP | 3.8% | 6.4% | 62.1% |
| S&P BSE ALLCAP | 2.5% | 4.3% | 37.6% |
| S&P BSE HEALTHCARE | 1.9% | 3.3% | 54.4% |
| S&P BSE IPO | 1.2% | 2.2% | 68.3% |
No NSE index found
You may also like the below Video Courses
FAQ about INNOVA CAPTAB Financials
How the annual revenues of INNOVA CAPTAB have changed ?
The Revenues of INNOVA CAPTAB have increased by 15.72% YoY .
How the Earnings per Share (EPS) of INNOVA CAPTAB have changed?
The Earnings Per Share (EPS) of INNOVA CAPTAB has decreased by -97.34 % YoY .
Check out Intrinsic Value of Peers of INNOVA CAPTAB
Compare Stock Analytics of Peers of INNOVA CAPTAB
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs
